Anti-Idiotypic Antibody Production Service

 

Anti-ID_SellSheet_Web-1.png

For more than twenty-five years, Rockland has been producing customized anti-idiotype (anti-ID) antibodies for the detection, identification, and analysis of therapeutic drugs to support pre-clinical and downstream clinical trials. Anti-ID antibodies can be produced as polyclonal or hybridoma-based monoclonal antibodies depending on the needs of your study. These fit-for-purpose antibodies can be generated in a variety of hosts for use in studies to identify, neutralize, block, and assess the properties of drug-to-analyte binding on the target therapeutic antibody.